60 Degrees Pharmaceuticals (SXTP) Assets (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Assets of $6.8 million for Q1 2026, up 13.14% year-over-year from $6.0 million in Q1 2025, and up 26.04% quarter-over-quarter from $5.4 million in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Assets (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Assets for 5 consecutive years, with $6.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 13.14% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $6.8 million (up 13.14% YoY), while the FY2025 annual figure was $5.4 million, down 6.83% from the prior year.
- Assets rose to $6.8 million in Q1 2026 per SXTP's latest filing, from $5.4 million in the prior quarter.
- Across five years, Assets topped out at $9.2 million in Q3 2023 and bottomed at $1.3 million in Q4 2022.
- Historically, Assets has averaged $6.2 million across 5 years, with a median of $6.7 million in 2025.
- Annual changes were most pronounced in 2023 — Assets surged 500.04% — and 2024, when it tumbled 41.2%.
- 60 Degrees Pharmaceuticals' Assets stood at $1.3 million in 2022, then soared by 500.04% to $7.8 million in 2023, then dropped by 26.01% to $5.8 million in 2024, then retreated by 6.83% to $5.4 million in 2025, then increased by 26.04% to $6.8 million in 2026.
- Business Quant data shows SXTP's Assets at $6.8 million in Q1 2026, $5.4 million in Q4 2025, and $6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 19.82 Bn |
| 10 | 60 Degrees Pharmaceuticals | 3.01 Mn | 1.99 Mn | 56,798.00 | 4.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.76 Mn |
| Dec 31, 2025 | 5.37 Mn |
| Sep 30, 2025 | 6.69 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Mar 31, 2025 | 5.98 Mn |
| Dec 31, 2024 | 5.76 Mn |
| Sep 30, 2024 | 7.42 Mn |
| Jun 30, 2024 | 4.33 Mn |
| Mar 31, 2024 | 8.38 Mn |
| Dec 31, 2023 | 7.78 Mn |
| Sep 30, 2023 | 9.15 Mn |
| Jun 30, 2023 | 7.36 Mn |
| Dec 31, 2022 | 1.30 Mn |